Japan Gold
Japan Gold Corp.
  • Japan Gold (JG) has closed the first tranche of a non-brokered private placement for gross proceeds of $5,700,000
  • Japan Gold intends to use the proceeds for drilling, drill targeting, advancing the prospect pipeline from the company’s large portfolio of exploration projects, and for general working capital purposes
  • Japan Gold is a Canadian mineral exploration company, focusing solely on gold exploration across the three largest islands of Japan
  • Japan Gold Corp. (JG) was down 2.78 per cent, trading at C$0.175 per share at 5:05 pm ET

Japan Gold (JG) has closed the first tranche of a non-brokered private placement for gross proceeds of $5,700,000.

In the first tranche of the offering, the company issued 28,500,000 shares at $0.20 per share. An insider of the company also subscribed for 15,000,000 shares for aggregate gross proceeds of $3,000,000.

In connection with the offering, the company paid $275,000 in cash and issued 1,925,000 finder’s warrants to arm’s length finders. The finder’s warrants are exercisable at C$0.20 per share for a period of 12 months from the date of closing.

Japan Gold intends to use the proceeds for drilling, drill targeting, advancing the prospect pipeline from the company’s large portfolio of exploration projects, and for general working capital purposes.

All securities issued will be subject to a statutory hold period of four months expiring on September 10, 2023.

About Japan Gold

Japan Gold is a Canadian mineral exploration company. It focuses solely on gold exploration across the three largest islands of Japan: Hokkaido, Honshu, and Kyushu.

The company holds a portfolio of 34 gold projects which cover areas with known gold occurrences, a history of mining and are prospective for high-grade epithermal gold mineralization. 

Japan Gold Corp. (JG) was down 2.78 per cent, trading at C$0.175 per share at 5:05 pm ET.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

More From The Market Online

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech, a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.

ESE producing championship e-sports tournament for Riot Games

ESE Entertainment’s (TSXV:ESE) media production unit, Frenzy, takes on the distribution of the upcoming Teamfight Tactics e-sports tournament.

4 stocks to consider after Microsoft’s 2024 study on AI at work

Microsoft (NASDAQ:MSFT) on Wednesday released the 2024 Work Trend Index, which looks into the state of artificial intelligence at work.

Buzz on the Bullboards: Who benefits from the latest stock market rally?

Investors are eagerly anticipating top corporate earnings this week, seeking further insights into market trends and potential opportunities.